Binu John MD MPH
Hepatology & Liver Transplantation
Chief of Gastroenterology and Hepatology, Miami VA Medical Center, Miami FL
Join to View Full Profile
1201 16th St nwMiami, FL 33125
Phone+1 305-575-7000
Dr. John is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Binu John is a gastroenterologist and hepatologist in Miami, FL. He specializes in hepatology & liver transplantation, is an Affiliate Associate Professor, University of Miami Miller School of Medicine and Chief of Hepatology at the Bruce W Carters VA Medical Center. He is experienced in hepatology, transplant hepatology, portal hypertension, and hepatocellular carcinoma.
Education & Training
Cleveland Clinic FoundationFellowship, Gastroenterology, 2007 - 2010- Cleveland Clinic FoundationResidency, Internal Medicine, 2005 - 2007
Christian Medical College VelloreClass of 1998
Certifications & Licensure
FL State Medical License 2013 - 2027
VA State Medical License 2016 - 2022
OH State Medical License 2005 - 2018
American Board of Internal Medicine Gastroenterology- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Publications & Presentations
PubMed
- SGLT2 Inhibitors in Cirrhosis: A Promising Therapeutic Avenue with Potential Risks.Alejandro J Loyola-Vélez, Binu V John
Digestive Diseases and Sciences. 2025-02-01 - Mortality, Hepatic Decompensation, and Cardiovascular Outcomes in Lean vs. Non-lean MASLD Cirrhosis: A Veterans Affairs Cohort Study.Basile Njei, Catherine Mezzacappa, Binu V John, Marina Serper, David E Kaplan
Digestive Diseases and Sciences. 2025-02-01 - Identifying Metabolic Dysfunction-Associated Steatotic Liver Disease Using Natural Language Processing in a US National Cohort.Binu V John, Dustin Bastaich, Catherine Mezzacappa, Raphaella D Ferreira, Austen Hentschel
The American Journal of Gastroenterology. 2025-01-16
Press Mentions
Third COVID-19 Vaccine Dose Reduces Infection, Critical Disease Risk in Cirrhosis by 80%November 7th, 2022- Third Dose of COVID-19 Vaccine Offers Needed Boost in Protection for Cirrhosis PatientsOctober 26th, 2022
- Miller School Faculty Front and Center at DDW ’22June 28th, 2022
- Join now to see all
Grant Support
- Addition of F18-Piflufolastat PET/CT to Cross-Sectional Imaging for the Staging and Management of Hepatocellular CarcinomaMIAMI VA HEALTH CARE SYSTEM2024–2028
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
